New Insomnia Medication Found Effective
Posted on: Saturday, 25 October 2003, 06:00 CDT
HealthDayNews -- A new drug called eszopiclone (trade name Estorra) works in treating long-term insomnia, says a study in the Nov. 1 issue of Sleep.
During the six-month study, led by Duke University Medical Center, the drug was given nightly to patients with chronic insomnia. The patients taking the drug showed significant improvement in their ability to fall asleep and to stay asleep. They also experienced better quality of sleep.
There was no evidence of loss of drug effectiveness over time, the study says.
The improvement in sleep achieved by the patients taking the drug were associated with consistent improvements in the patients' ratings of their capacity to function well during the day.
This is the first time that any sleep medication has been shown to consistently improve all the components that define insomnia.
The double-blind, placebo-controlled study included 788 people aged 21 to 69. Those taking the drug were given 3 milligrams a night of eszopiclone.
"I believe that this study is a milestone for research into insomnia treatments," lead author Dr. Andrew Krystal, an associate professor of psychiatry and director of the Sleep Research Laboratory and Insomnia Clinic at Duke, says in a prepared statement.
"It greatly extends the period of time that a medication has been definitively shown to help people suffering from insomnia and it establishes that studies of longer-term drug treatment of insomnia are not only feasible but can be safely performed," he says.
Prior to this study, the longest large-scale, placebo-controlled study of a sleep medication for insomnia lasted five weeks.
-----
On the Net:
Duke University Medical Center
More science, space, and technology from RedNova
Copyright © 2003 HealthDay. All rights reserved. The information contained above is intended for general reference purposes only. It is not a substitute for professional medical advice or a medical exam. Always seek the advice of your physician or other qualified health professional before starting any new treatment. Medical information changes rapidly and while Yahoo and its content providers make efforts to update the content on the site, some information may be out of date. No health information on Yahoo, including information about herbal therapies and other dietary supplements, is regulated or evaluated by the Food and Drug Administration and therefore the information should not be used to diagnose, treat, cure or prevent any disease without the supervision of a medical doctor.
Related Articles
- Patients Say MPM Medical's Regenecare Gel Significantly Reduced the Itching and Pain of Skin Rashes Triggered by Anti-Cancer Drugs
- Pilot Study of Wellstar's Thermal Imaging Device Completed By Duke University Medical Center
- Duke University Medical Center and IBM Speed Up Access to Vital Patient Information
- Duke University Medical Center Publishes Report on Antifungal Drug Cost Savings of C. Albicans PNA FISH Implementation
- Medical Journal: Drug Studies Hide Key Data
- Lifetime Health Medical Group of Western New York to Provide Electronic Prescribing to 30,000 Additional Patients
- Role of Cholesterol Lowering Drugs in Heart Failure Patients Evaluated in Yale Medical Center's Heart Study
- University Studies Show Little Progress in New Mental Health Medication
- Heart Trouble Risk May Rise for Aleve Users: ; Drug Study Halted When Patients Suffered Heart Attacks, Strokes
- Patient Dies in VA Medical Study
User Comments (0)

RSS Feeds